A Rift Over Carl Linnaeus Shows We Shouldn’t Idolize Scientists
By Brian Lovett,
Undark
| 08. 06. 2020
The traditions we carry into the future, including who we choose to honor, should be able to withstand modern scrutiny.
WE ARE LIVING through a period of cultural upheaval. Around the world, statues of iconic men who held racist beliefs and committed racial injustices are being ripped from their pedestals. The dull thud of metal bodies hitting concrete rings fresh in our ears, and many of us are still grappling with what these reverberations mean.
Statues of racists are monuments to the dregs of our society. Yet over time, their pedestals have crept so high that, for some people, it has become unthinkable that any scandal could justify their removal. Today, these memorialized men look down on us from high places that they do not deserve; the scandal is that society has for so long respected the inertia of their corrupting influence.
One such figure is the 18th century Swedish botanist Carl Linnaeus. He devised binomial nomenclature, the ubiquitous system now used to scientifically classify organisms by genus and species. He then used his nomenclature to classify humans by “variety,” ascribing inherently positive traits to lighter-skinned Europeans and negative traits to darker-skinned Africans and Asians, thereby laying a pseudoscientific foundation for...
Related Articles
By Dan Barry and Sonia A. Rao, The New York Times | 01.26.2026
Photo by Gage Skidmore from Peoria, AZ, United States
of America, CC BY-SA 2.0, via Wikimedia Commons
Late last month, a woman posted a photograph on social media of a purple hat she had knitted, while a black-and-white dog...
By Shobita Parthasarathya, Science | 01.22.2026
These are extraordinarily challenging times for university researchers across the United States. After decades of government largess based on the idea that a large and well-financed research ecosystem will produce social and economic progress, there have been huge cuts in...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...